Ace the Case: R/R MM After 4 Lines of Therapy: What are the options?

Effective treatment of multiple myeloma (MM) requires significant clinical coordination, as MM treatment plans are highly individualized. Treatment is influenced by many factors, including patient demographics, biomarkers, level of disease progression, response to previous treatments, individual treatment goals, and the preferred treatment paradigms of individual practitioners.

This educational program is designed to meet the educational needs of the members of the care team (oncologists, hematologists, nurses, nurse practitioners, physician assistants, pharmacists and other health care professionals) who manage patients with relapsed/refractory multiple myeloma.